Cargando…
Immuno-Imaging (PET/SPECT)–Quo Vadis?
The use of immunotherapy has revolutionized the treatment regimen of certain cancer types, but response assessment has become a difficult task with conventional methods such as CT/MRT or FDG PET-CT and the classical response criteria such as RECIST or PERCIST which have been developed for chemothera...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147562/ https://www.ncbi.nlm.nih.gov/pubmed/35630835 http://dx.doi.org/10.3390/molecules27103354 |